Family Medicine
Systematic Review: Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
4 Mar, 2022 | 08:46h | UTC
Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts.
4 Mar, 2022 | 08:45h | UTCCommentaries:
Living a long life is a multi-step process – The Lancet Public Health
Podcast: Obesity medicine pearls.
4 Mar, 2022 | 08:43h | UTC#324: Obesity Medicine FAQ with Dr. Fatima Cody Stanford – The Curbsiders
WHO: COVID-19 pandemic triggers a 25% increase in the prevalence of anxiety and depression worldwide.
3 Mar, 2022 | 09:44h | UTCNews Release: COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide – World Health Organization
Scientific Brief: Mental health and COVID-19: Early evidence of the pandemic’s impact – World Health Organization
Commentary on Twitter (thread – click for more)
🆕 #COVID19 pandemic triggers 25% increase in prevalence of anxiety & depression worldwide: New WHO publication
More: https://t.co/QFiH7j312f#MentalHealth📷: Getty Images/J. Paget pic.twitter.com/iX15sbHXcW
— World Health Organization (WHO) (@WHO) March 2, 2022
RCT: Nirsevimab for prevention of RSV in healthy late-preterm and term infants.
3 Mar, 2022 | 09:42h | UTCCommentaries:
Nirsevimab Protects Late-Preterm, Term Infants from RSV-Related Lower RTI, Study Finds – AJMC
Nirsevimab Prophylaxis Wards Off RSV Infections in Healthy Infants— Monoclonal antibody showed 74.5% efficacy against RSV infections requiring medical care – MedPage Today (free registration required)
Related: Randomized trial: Single-dose nirsevimab for prevention of RSV in preterm infants
National, regional, and global causes of mortality in 5–19-year-olds from 2000 to 2019: a systematic analysis.
3 Mar, 2022 | 08:51h | UTCInvited commentary: Child and adolescent deaths: a call for strengthening mortality surveillance systems – The Lancet Global Health
[News release – not published yet] Study finds blood pressure cuff size matters, affects blood pressure readings.
3 Mar, 2022 | 08:47h | UTCStudy finds blood pressure cuff size matters, affects blood pressure readings – AHA Newsroom
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
3 Mar, 2022 | 08:43h | UTCMyocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong – JAMA Pediatrics
Commentary: Study: Dosing change could reduce COVID-19 vaccine heart side effect in teens – UPI
Related:
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
A low-energy diet shows promise for reducing the symptoms of fibromyalgia.
3 Mar, 2022 | 08:23h | UTCEarly Relationships of a Low-Energy Diet With Symptoms of Fibromyalgia ACR Open Rheumatology
Commentary: Fibromyalgia Patients See Rapid Benefit From Low-Cal Diet — With marked symptom reduction in just 3 weeks, weight loss not a factor – MedPage Today (free registration required)
The effects of foods on LDL cholesterol levels: A systematic review of the accumulated evidence from systematic reviews and meta-analyses of randomized controlled trials.
3 Mar, 2022 | 08:22h | UTC
Meta-analysis showed a 2.4-fold increased risk of cancer in patients with pediatric-onset inflammatory bowel disease.
3 Mar, 2022 | 08:06h | UTCCommentary: Kids With IBD Need Close Monitoring as They Grow Up — Meta-analysis confirms: substantially increased cancer risk in adulthood – MedPage Today (free registration required)
Concise Review: A Practical 5-step approach to nausea and vomiting.
3 Mar, 2022 | 08:04h | UTCA Practical 5-Step Approach to Nausea and Vomiting – Mayo Clinic Proceedings
M-A: Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma.
3 Mar, 2022 | 07:59h | UTC
Erosive hand osteoarthritis: latest findings and outlook.
3 Mar, 2022 | 08:01h | UTCErosive hand osteoarthritis: latest findings and outlook – Nature Reviews Rheumatology (if the link is paywalled, try this one)
Commentary on Twitter
#MarchIssue | Read our #Review on the clinical features and risk factors of erosive hand #osteoarthritis (an aggressive condition with poor outcomes), and progress in biomarkers, imaging, classification and treatmenthttps://t.co/GSvgnXYYPS pic.twitter.com/PSzeucO0cH
— NatRevRheumatol (@NatRevRheumatol) February 28, 2022
Prescribing Nirmatrelvir–Ritonavir for Covid-19: How to recognize and manage drug–drug interactions.
2 Mar, 2022 | 09:01h | UTCRelated:
Pfizer antiviral pills may be risky with other medications – NBC News
Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week.
2 Mar, 2022 | 09:03h | UTCCommentary: Review of Anticoagulation in Patients With COVID-19: Key Points – American College of Cardiology
RCT: Arthroscopic hip surgery compared with personalized hip therapy in people over 16 years old with femoroacetabular impingement syndrome.
2 Mar, 2022 | 09:04h | UTC
NICE Guideline: Mental wellbeing at work.
2 Mar, 2022 | 08:57h | UTCMental wellbeing at work – National Institute for Health and Care Excellence
Systematic Review: Postcholecystectomy diarrhea rate and predictive factors.
2 Mar, 2022 | 08:48h | UTC
Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.
1 Mar, 2022 | 08:58h | UTCTiming of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia
Related:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Systematic review on inappropriate use of clinical practices in Canada identified 144 underused practices, 109 overused practices, and 25 practices that were both under- and overused.
1 Mar, 2022 | 08:52h | UTCNews Release: Inappropriate use of 228 clinical practices in Canada – Canadian Medical Association Journal
[Preprint] Study shows significantly reduced effectiveness of the Pfizer vaccine in children 5 to 11 after the emergency of the Omicron variant.
1 Mar, 2022 | 08:54h | UTCCommentaries:
Pfizer Covid vaccine is less effective in kids 5 to 11, study finds – STAT
More mask mandates fall as poor COVID vaccine protection noted in young kids – CIDRAP
RCT: A mindfulness-oriented intervention may reduce opioid misuse and chronic pain in primary care.
1 Mar, 2022 | 08:32h | UTCMindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial – JAMA Internal Medicine (link to abstract – $ for full-text)
Commentary: Mindfulness-Based Intervention Found to Reduce Chronic Pain and Opioid Misuse – Psychiatric News Alert
Commentary on Twitter
A randomized clinical trial showed that #Mindfulness-Oriented Recovery Enhancement delivered in the primary care setting reduces opioid misuse by as much as 46%, while simultaneously reducing chronic pain and emotional distress. https://t.co/eNj42RBCRA @DrEricGarland pic.twitter.com/tBatMT9lkQ
— JAMA Internal Medicine (@JAMAInternalMed) February 28, 2022
Review: New generation psychological treatments in chronic pain.
1 Mar, 2022 | 08:41h | UTCNew generation psychological treatments in chronic pain – The BMJ (free for a limited period)
New CDC interim guidance recommends a 4-month Rifapentine-Moxifloxacin regimen to treat drug-susceptible pulmonary tuberculosis.
27 Feb, 2022 | 22:49h | UTCRelated:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO Guideline: Screening for Tuberculosis Disease
New WHO Recommendations to Prevent Tuberculosis
CDC Guidelines for the Treatment of Latent Tuberculosis Infection
Guideline: Treatment of Drug-Resistant Tuberculosis
The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis
Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives
Guidelines for the Management of TB in Adults Living with HIV
Commentary on Twitter
Clinicians: @CDC_TB released interim guidance on a new regimen to treat #TB disease. Learn more about the 4-month regimen containing rifapentine, moxifloxacin, isoniazid, and pyrazinamide for people with drug-susceptible pulmonary TB disease in the U.S.: https://t.co/eOcR34tYJu pic.twitter.com/EFGMwAwN7c
— MMWR (@CDCMMWR) February 25, 2022


